Dossier · CCJ · Watchlist
CCJ · Cameco Corporation · Stock research
Last analysed ·
Current thesis
Nuclear-uranium theme MATURING and CCJ's structure has broken twice into improving news: mkt cap $44.79B (06-29) → ~$39.9B (07-25), ~$88, ~35% off the $135.24 high, absorbing a $17.5B federal AP1000 program and NJ's $24B plan. Barclays cut to Equal-Weight, PT $104 (07-16). Q2 print 2026-07-31 (EPS est $0.26, −49% YoY) is the binary; no setup until a higher-low reclaim of ~$104.
Invalidation trigger
A weekly close below $85 turns the twice-broken structure into a trend, losing the July shelf and opening the $68.96 base; confirmed fundamentally by a Q2 delivery guide cut below 29–32M lb or a realized-price guide under $85/lb on the ~2026-07-31 print. A failed reclaim at ~$104 on thin volume marks a third lower high.
Thesis status
Invalidated resolved published trigger fired How this is scored →Latest analysis and events for CCJ —
As of 2026-08-05, orbyd's latest analysis for Cameco Corporation (CCJ): Note of 2026-07-16: the $100 shelf FAILED — market cap $38.27B implies ~$88/share on ~435M shares. Last week's thesis-break level was hit. Structure is now twice-broken (~$115 rejection, then ~$100 loss).
Invalidation trigger: A weekly close below $85 turns the twice-broken structure into a trend, losing the July shelf and opening the $68.96 base; confirmed fundamentally by a Q2 delivery guide cut below 29–32M lb or a realized-price guide under $85/lb on the ~2026-07-31 print. A failed reclaim at ~$104 on thin volume marks a third lower high.
Next dated event on file: — catalyst in 5d.
Current Thesis
The bounce off the post-print low picked up volume on 2026-08-04. That is +7.8% over two sessions from the 2026-07-31 close of $86.38, and 08-04's low of $91.00 opened above 08-03's $89.91 high, leaving an unfilled gap. Market cap $40.56B.
Arriving alongside it was the first sell-side mark down toward the tape. Barclays kept Equal-Weight and cut its target to $97 from $104 on 2026-08-04 — the second cut from that desk in three weeks, after $108 → $104 on 2026-07-16. At the 08-04 close that target sits 4.2% above the price. Stifel maintained Buy at $128 the same day. Consensus across 24 analysts is $129.20 (11 Strong Buy / 9 Buy / 4 Hold / 0 Sell), median $134.67, range $84.22–$174.57. One desk has converged to the price; the rest of the distribution has not moved.
Structure is unchanged where it counts. The 50-day moving average is $99.04 and the 200-day $104.56, both sloping down, and $93.09 sits under both. The reclaim zone the mid-July break defined — roughly $99 to $105 — has not been touched since. Two prior bounces failed at about $115 in June and about $100 in mid-July; what distinguishes this one so far is only that it started from an intraday $85.02 on 2026-08-03 rather than from a lower high.
Life-cycle: SATURATED. The label dates to 2026-07-31, when a +4.3% premarket bid on raised realized-price guidance was gone by a $86.38 close, and nothing since has reversed it. Supporting observables: Barclays cutting a second time on 2026-08-04 while the tape rose; the Global X Uranium ETF at $39.07 on 2026-08-03 against a 52-week range of $35.64–$62.28, placing the de-rating across the whole complex; retail-format "$100 invested five years ago" pieces on 2026-07-16 and again on 2026-07-31; and no higher high since $135.24 despite a $17.5B DOE conditional commitment for AP1000 long-lead items, New Jersey's $24B nuclear plan (2026-07-14) and an 18-year-high term uranium price. The volume expansion on 08-04 is the first datapoint arguing the other way, and it is one session.
Bullish and bearish views on Cameco Corporation
The model's bull view on Cameco Corporation (CCJ), in brief: 2026 realized-price guidance raised to $91.00–96.00/lb on 2026-07-31, with consolidated revenue guidance raised to C$3,320–3,570M and the uranium segment to C$2,700–2,910M, attributed to contract pricing rather than volume. The bear view: Costs inflated faster than price. Q2 2026 produced-and-purchased unit cost C$62.21/lb, +36% YoY, against realized C$93.13/lb, +15% YoY. Uranium production 3.9M lb, −15% YoY. Adjusted EPS US$0.13 against a $0.36 vendor consensus (2026-07-31). Westinghouse decelerated hard.… Both cases follow in full.
Bull Case
- 2026 realized-price guidance raised to $91.00–96.00/lb on 2026-07-31, with consolidated revenue guidance raised to C$3,320–3,570M and the uranium segment to C$2,700–2,910M, attributed to contract pricing rather than volume.
- Contract book carries five-year visibility: management disclosed average annual deliveries above 28M lb over the next five years, with floors in the high $70s/lb and ceilings near $160/lb escalated (Q2 2026 call, 2026-07-31).
- Westinghouse has a path to a public mark. The confidential draft Form S-1 was announced 2026-07-31; Desjardins values Cameco's 49% stake at about C$15.1B, and Scotia flagged the timing as several years earlier than expected, with the window extendable to 2029. Nothing in the $40.56B market cap is an observed mark on that stake.
- AP1000 pipeline quantified: 91 identified deployment opportunities totalling roughly 105 GWe, near-term overnight capital.
- Production outlook untouched at 19.5–21.5M lb U3O8 through the May 2026 McArthur River/Key Lake flooding suspension — both since returned to full production activities — and the 2026-07-01 Cigar Lake mill stoppage, whose ore shipments resumed 2026-07-15.
- Inventory carried far below realization: 8.7M lb U3O8 at an average C$58.05/lb at 2026-06-30, against C$93.13/lb realized in Q2.
- BlackRock crossed 5%: 21,875,115 shares, 5.02% of the class as of 2026-06-30, Schedule 13G accepted by EDGAR 2026-07-27 — a holder building in the quarter the structure broke.
- The target distribution still skews high: Stifel Buy $128 (2026-08-04), RBC Buy $125 (2026-07-31), UBS upgraded to Buy $118 (2026-07-27).
Bear Case
- Costs inflated faster than price. Q2 2026 produced-and-purchased unit cost C$62.21/lb, +36% YoY, against realized C$93.13/lb, +15% YoY. Uranium production 3.9M lb, −15% YoY. Adjusted EPS US$0.13 against a $0.36 vendor consensus (2026-07-31).
- Westinghouse decelerated hard. Cameco's share of adjusted EBITDA was C$163M in Q2 2026 versus C$352M in Q2 2025, a 54% decline; share of net was a C$10M loss. Management attributed the year-over-year gap primarily to the absence of a large Dukovany-related contribution.
- H2 has to carry the delivery book. H1 deliveries were 14.9M lb against a maintained 29–32M lb annual guide, leaving 14.1–17.1M lb for the second half.
- Sprott's end-June long-term price of $94/lb was an 18-year high, yet H1 2026 ran spot +4.3% while uranium mining equities fell 3.9%.
- A second Barclays cut in three weeks ($108 → $104 on 2026-07-16 → $97 on 2026-08-04) shows the target distribution converging down to the tape rather than the tape rising into it.
- Valuation leaves no room for a delivery slip: trailing P/E 163.20 and forward P/E 68.22 at the $93.09 close, on EPS of $0.57.
- The same print circulated as both a raise and a cut on 2026-07-31 newswires — a consequence of Canadian-dollar reporting and segment-versus-consolidated framing on US data feeds. Screens built on vendor USD revenue lines will disagree with the MD&A.
Setup & Price Structure
- $85 is the level that decides. The 2026-08-03 session traded an intraday low of $85.02 and closed $89.72, so the shelf the mid-July break projected has now been touched once and held once. A weekly close below $85 converts a twice-broken structure into a trend and opens the $68.96 52-week low.
- Overhead is stacked and falling: 50-day $99.04, 200-day $104.56 as of 2026-08-04. The mid-July shelf that failed sits inside the same $99–$105 band, so the moving-average reclaim and the structural reclaim are one event.
- The 08-04 gap is unfilled — 08-03 high $89.91 against 08-04 low $91.00. Losing $91.00 fills it and returns the tape into the post-print range.
- Distance from the high: $93.09 against a $135.24 52-week high, 31.2% below, with no higher high printed since.
- No squeeze mechanics: short interest 6.66M shares, 1.53% of 435.53M outstanding, down from 6.81M the prior month. Beta (5Y) 0.99.
- No company binary inside the window. Q2 reported 2026-07-31 and Q3 is not expected until early November, so the term-price prints and the 13F deadline are the only dated resolvers for the next month.
Catalyst Calendar (next 30 days)
- 2026-08-14 — Q2 2026 13F filing deadline. First observable on whether institutional holders added into the mid-July structural break near $100 or reduced through it.
- ~2026-08-31 (est.) — August UxC long-term uranium price publication. The raised $91.00–96.00/lb realized-price guide rests on the term price holding near the $94/lb Sprott reported at end-June 2026.
- ~2026-08-31 (est.) — August uranium spot settle. Spot has sat near $86/lb since late July against $99/lb on 2026-01-28; the spot-to-term spread determines how fast utilities move from watching to contracting.
- 2026-09-09 to 2026-09-11 — World Nuclear Symposium, Hilton London Metropole (just past the 30-day boundary). WNA fuel-cycle supply and demand projections are reset here, and the term uranium market prices off them.
Elapsed catalysts
- Undated, ~2026-H2 — public flip of the Westinghouse Form S-1. Management declined to discuss offering size, price range or timing on the 2026-07-31 call, citing SEC rules, so this has no scheduled date and could land inside the window. (passed 9d ago)
What Would Change Our Mind
The structural question is whether the $99–$105 band gets reclaimed or rejected a third time. A daily close back above the 50-day at $99.04, followed by a higher high through the failed mid-July shelf on volume at or above the 3.80M 20-day average, would end the sequence that runs $135.24 → about $115 in June → about $100 in mid-July and argue the theme is MATURING rather than SATURATED. Without that, the two-session bounce is a retracement inside a downtrend, and a third rejection near $99 on thin volume marks the pattern's continuation.
On the downside, a weekly close below $85 breaks the shelf that 2026-08-03's $85.02 intraday low defined and opens the $68.96 base. The confirming fundamentals would be a Q3 delivery print below roughly 7M lb against H1's 14.9M lb and the maintained 29–32M lb guide, or two consecutive monthly UxC term prints under roughly $90/lb, either of which undercuts the $91.00–96.00/lb realized-price guide the 2026-07-31 raise was built on.
The event that resolves the widest gap is the Westinghouse S-1. If it flips public carrying a price range that implies an equity value below the roughly C$15.1B Desjardins marks the 49% stake at, the sum-of-parts support beneath the $129.20 consensus goes with it. If it has not flipped public by the Q3 print in early November, the "several years earlier than expected" framing loses its urgency and the stake stays an unmarked line on the sell side's models.
Correlation Notes
- Sector beta dominates. URA closed $39.07 on 2026-08-03 against a 52-week range of $35.64–$62.28, so the de-rating that carried CCJ from $135.24 into the $86–93 area is complex-wide, and single-name news has had limited power to separate it.
- Spot and equities diverged in H1 2026: spot +4.3% while uranium mining equities fell 3.9%, with the long-term price at an 18-year-high $94/lb at end-June. The commodity leg and the equity leg have not been the same exposure this year.
- Brookfield sits on the other side of Westinghouse. Brookfield Renewable holds 51% to Cameco's 49%; S-1 headlines move both, and any offering price range marks the Cameco stake by arithmetic.
- The dual listing splits the signal: CCJ on NYSE and CCO on TSX, with analyst targets published in both currencies. The 2026-07-16 Barclays action circulated as both US$104 and C$147.
- AI-power adjacency is the headline transmission channel — the $17.5B DOE conditional commitment, New Jersey's $24B plan on 2026-07-14 — while the P&L is a uranium contract book, and Q2's miss traced to unit cost and to Westinghouse rather than to data-center demand.
Notes
- 2026-04-19: Cameco — uranium miner
- 2026-07-16: the $100 shelf FAILED — market cap $38.27B implies ~$88/share on ~435M shares. Last week's thesis-break level was hit. Structure is now twice-broken (~$115 rejection, then ~$100 loss).
- Cameco reports in Canadian dollars; USD revenue and EPS on US data feeds are vendor FX conversions, which is why the same print circulated as both a beat and a miss.
- Westinghouse is 49%-owned and equity-accounted: it lands in Cameco's share of adjusted EBITDA, not consolidated revenue, so the uranium segment revenue guide excludes it.
- Dual-listed as CCJ on NYSE and CCO on TSX; analyst targets are published in both currencies and are routinely quoted without the currency label attached.
- The confidential Westinghouse S-1 carries SEC quiet-period limits: management declined to discuss offering size, price range or timing on the 2026-07-31 call.
- Production is concentrated in a few Saskatchewan assets; 2026 has already seen a McArthur River/Key Lake flooding suspension and a Cigar Lake mill stoppage.
- Newswire feeds intermittently mis-tag unrelated stories to this ticker, including the 2026-07-17 Cheche Group reverse-split headline.
Related · shared themes
CEG
Constellation Energy Corporation
Uncontracted nuclear baseload repriced by AI load, with the bid not confirming: CEG fell 2.36% to $267.25 on 2026-08-04 while the S&P 500 closed at a record 7,737 (+1.79%). No new large-load offtake since 2026-06-23. The 2026-08-06 Q2 print — consensus $2.24 EPS on $7.51B revenue — is the binary.
NNE
Nano Nuclear Energy Inc.
Nuclear-microreactor narrative has stopped converting news into demand: a Truist Hold/$22 initiation (7/14) and a Virginia consortium announcement (7/17) landed inside four sessions and NNE still printed a fresh 52-week low at $15.78 (7/16), losing the prior $18.04 floor. Broken structure, $400M ATM armed against a ~$844M cap, first KRONOS revenue ~FY2030. Stand aside until a base forms above $22.
OKLO
Oklo Inc.
Three straight cohort-driven sessions carried OKLO from the 2026-07-29 close of $36.84 to $43.33 on 2026-08-04, with no Oklo release behind any of them. The 2026-08-07 Q2 call is the binary.
SMR
NuScale Power Corporation
Second up-day into tonight's print with nothing new disclosed: SMR closed $9.49 on 2026-08-04 (+5.33%), 25% above the 2026-07-29 base and still under a falling $9.90 50-day. Q2 consensus spans $1.0M (Zacks) to $8.80M (MarketBeat) on a $565K Q1 base; the only live asset is an unsigned end-2026 TVA PPA, and the 2026-08-05 call is the binary.
See also · stocks to watch